Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (321-330 of 587) with videos related to

Pageof 59
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 2, 2020
The Association Between Serum Thyrotropin Within the Reference Range and Metabolic Syndrome in a Community-Based Chinese PopulationMeng Li, Xiuying Zhang, Xianghai Zhou, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 4, 2020
Association Between Abnormal Glycemic Phenotypes and Microvascular Complications of Type 2 Diabetes Mellitus Outpatients in ChinaGuangxu Liu, Jingtao Dou, Deqiang Zheng, et al.
Cardiovascular Diabetology|February 7, 2025
Predicting cardiovascular outcomes in Chinese patients with type 2 diabetes by combining risk factor trajectories and machine learning algorithm: a cohort studyQi Huang, Xiantong Zou, Zhouhui Lian, et al.
Iscience|November 9, 2023
Personalized glucose-lowering effect of chiglitazar in type 2 diabetesQi Huang, Xiantong Zou, Yingli Chen, et al.
Annals of Clinical and Translational Neurology|April 25, 2018
Diabetes and obesity are the main metabolic drivers of peripheral neuropathyBrian C Callaghan, LeiLi Gao, Yufeng Li, et al.
Diabetes, Obesity & Metabolism|July 24, 2020
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysisPhilip Home, Lawrence Blonde, Sanjay Kalra, et al.
Diabetes, Obesity & Metabolism|November 21, 2024
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RAMengqing Zhang, Chu Lin, Xiaoling Cai, et al.
Endocrine Connections|November 4, 2024
Clinical features and search for genetic determinants of postprandial hypoglycaemiaQian Ren, Xueyao Han, Siqian Gong, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 11, 2019
Urinary C-Peptide Creatinine Ratio as a Non-Invasive Tool for Identifying Latent Autoimmune Diabetes in Adults (LADA)Wei Liu, Xingquan Huang, Xiuying Zhang, et al.
Journal of Diabetes and Its Complications|October 24, 2020
Association of serum fibroblast growth factor 21 and urinary glucose excretion in hospitalized patients with type 2 diabetesRui Zhang, Xiaoling Cai, Yongrui Du, et al.
Pageof 59

Showing results (321-330 of 587) with videos related to

Sort By:
Pageof 59
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 2, 2020
The Association Between Serum Thyrotropin Within the Reference Range and Metabolic Syndrome in a Community-Based Chinese PopulationMeng Li, Xiuying Zhang, Xianghai Zhou, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 4, 2020
Association Between Abnormal Glycemic Phenotypes and Microvascular Complications of Type 2 Diabetes Mellitus Outpatients in ChinaGuangxu Liu, Jingtao Dou, Deqiang Zheng, et al.
Cardiovascular Diabetology|February 7, 2025
Predicting cardiovascular outcomes in Chinese patients with type 2 diabetes by combining risk factor trajectories and machine learning algorithm: a cohort studyQi Huang, Xiantong Zou, Zhouhui Lian, et al.
Iscience|November 9, 2023
Personalized glucose-lowering effect of chiglitazar in type 2 diabetesQi Huang, Xiantong Zou, Yingli Chen, et al.
Annals of Clinical and Translational Neurology|April 25, 2018
Diabetes and obesity are the main metabolic drivers of peripheral neuropathyBrian C Callaghan, LeiLi Gao, Yufeng Li, et al.
Diabetes, Obesity & Metabolism|July 24, 2020
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysisPhilip Home, Lawrence Blonde, Sanjay Kalra, et al.
Diabetes, Obesity & Metabolism|November 21, 2024
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RAMengqing Zhang, Chu Lin, Xiaoling Cai, et al.
Endocrine Connections|November 4, 2024
Clinical features and search for genetic determinants of postprandial hypoglycaemiaQian Ren, Xueyao Han, Siqian Gong, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 11, 2019
Urinary C-Peptide Creatinine Ratio as a Non-Invasive Tool for Identifying Latent Autoimmune Diabetes in Adults (LADA)Wei Liu, Xingquan Huang, Xiuying Zhang, et al.
Journal of Diabetes and Its Complications|October 24, 2020
Association of serum fibroblast growth factor 21 and urinary glucose excretion in hospitalized patients with type 2 diabetesRui Zhang, Xiaoling Cai, Yongrui Du, et al.
Pageof 59